What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It consists of 15 amino acids and has been studied extensively in animal models for its regenerative and protective properties across multiple tissue types. While it has not received FDA approval for any indication, it has become one of the most widely discussed peptides in sports medicine, integrative health, and gastroenterology circles.

BPC-157 is available exclusively through compounding pharmacies, as it is not an FDA-approved drug and not commercially manufactured.

What Is BPC-157 Used For?

The primary areas of interest for BPC-157 include tendon, ligament, and muscle repair, making it popular among athletes and people recovering from orthopedic injuries. It's also studied for gut healing — particularly for conditions like inflammatory bowel disease, leaky gut, and gastroparesis — due to its apparent effects on gut wall integrity and motility.

Additional areas of use reported by patients and practitioners include nerve regeneration, wound healing, bone healing, and systemic anti-inflammatory effects. Some research suggests it may influence dopamine and serotonin pathways, though this area is less developed.

What Does the Research Show?

The honest answer is that most BPC-157 research is in animals — primarily rats and mice. The results in rodent models have been consistently impressive across injury types, which is part of why interest in the peptide has grown so rapidly. However, robust human clinical trials are largely absent. The gap between animal and human evidence is a legitimate limitation that practitioners and patients should weigh carefully.

That said, the absence of human trials is partly a function of economics — synthetic peptides are difficult to patent, which reduces pharmaceutical industry incentive to fund large trials. The preclinical evidence is mechanistically plausible and the compound appears to be well-tolerated in the reports that exist.

Forms and Dosing

BPC-157 is available in two primary forms from compounding pharmacies. Injectable BPC-157 is administered subcutaneously, often near the site of injury for musculoskeletal applications, and is considered to have higher bioavailability for systemic effects. Oral BPC-157 capsules are more commonly used for gut-related applications and are easier to administer.

Common dosing protocols run 250–500mcg once or twice daily for 4–12 weeks, though protocols vary significantly by practitioner and indication. BPC-157 is typically cycled rather than used indefinitely.

Cost of Compounded BPC-157

Pricing from compounding pharmacies varies by formulation and quantity. Injectable BPC-157 (typically supplied as a lyophilized powder for reconstitution) runs approximately $60 to $150 for a month's supply. Oral capsules are generally $50 to $100 per month. Because BPC-157 is not FDA-approved, it is not covered by insurance.

Is BPC-157 Legal?

BPC-157 occupies a gray area. It is not FDA-approved, but it is not explicitly scheduled or banned. Compounding pharmacies can prepare it for patients with a valid prescription, though some pharmacies are more cautious about offering it than others. In 2022, the FDA issued guidance suggesting certain peptides including BPC-157 should not be compounded, though enforcement has been inconsistent and practitioners continue to prescribe it.

If you're pursuing BPC-157, work with a knowledgeable prescriber and a reputable 503A or 503B compounding pharmacy that provides third-party testing documentation.

Bottom Line

BPC-157 has a compelling preclinical profile for tissue repair and gut healing, though human evidence remains limited. It's widely used in integrative and sports medicine settings. If you're considering it, find a practitioner familiar with peptide therapy and compare pharmacy options carefully.

CompoundingFinder connects you with licensed compounding pharmacies. Submit your prescription details to compare BPC-157 prices and receive quotes within 1–2 business days.